This is an old revision of this page, as edited by Beetstra (talk | contribs) at 10:47, 9 April 2012 (Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'ChEBI', 'StdInChI', 'StdInChIKey').). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 10:47, 9 April 2012 by Beetstra (talk | contribs) (Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'ChEBI', 'StdInChI', 'StdInChIKey').)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compoundClinical data | |
---|---|
Other names | Betamethasone-17,21-dipropionate |
AHFS/Drugs.com | Monograph |
Routes of administration | topical |
Legal status | |
Legal status |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.024.551 |
Chemical and physical data | |
Formula | C28H37FO7 |
Molar mass | 504.59 g/mol g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
|
Betamethasone dipropionate is a glucocorticoid steroid with anti-inflammatory and immunosuppressive abilities. It is applied as a topical cream, ointment, lotion or gel (Diprolene) to treat itching and other minor skin conditions such as eczema.
Brand names include Alphatrex, Beta-Val, Diprolene, Diprolene AF, Diprosone, and Luxiq.
Minor side effects include dry skin and mild, temporary stinging when applied.
References
- "FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA. Retrieved 22 Oct 2023.
- "Betamethasone Dipropionate Side Effects", drugs.com
See also
This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it. |